{
“@context”: “https://schema.org”,
“@type”: “Article”,
“mainEntityOfPage”: {
“@type”: “WebPage”,
“@id”: “https://www.clinicalstudies.in/sop-for-vaccine-trial-cold-chain-management-mass-trials”
},
“headline”: “SOP for Vaccine Trial Cold-Chain Management (Mass Trials)”,
“description”: “This SOP defines standardized procedures for cold-chain management in vaccine clinical trials, particularly mass vaccination trials. It ensures compliance with FDA, EMA, CDSCO, WHO, and ICH GCP requirements, covering receipt, storage, transport, monitoring, accountability, and deviation handling of vaccines.”,
“author”: {
“@type”: “Organization”,
“name”: “ClinicalStudies.in”
},
“publisher”: {
“@type”: “Organization”,
“name”: “ClinicalStudies.in”,
“logo”: {
“@type”: “ImageObject”,
“url”: “https://www.clinicalstudies.in/logo.png”
}
},
“datePublished”: “2025-08-26”,
“dateModified”: “2025-08-26”
}
Published on 22/12/2025
Standard Operating Procedure for Vaccine Trial Cold-Chain Management (Mass Trials)
| SOP No. | CR/OPS/115/2025 |
| Supersedes | NA |
| Page No. | 1 of 62 |
| Issue Date | 26/08/2025 |
| Effective Date | 01/09/2025 |
| Review Date | 01/09/2026 |
Purpose
The purpose of this SOP is to establish standardized procedures for cold-chain management of vaccines in clinical trials, with
Scope
This SOP applies to sponsors, CROs, investigators, site pharmacists, couriers, and laboratory staff involved in the receipt, storage, transport, and distribution of vaccines used in clinical trials. It covers cold-chain monitoring, accountability, excursion management, multi-site logistics, and regulatory compliance.
Responsibilities
- Sponsor: Ensures validated cold-chain systems are in place and audits compliance.
- Investigator: Oversees vaccine receipt, storage, and distribution at site level.
- Pharmacist/Site Staff: Responsible for storage, monitoring, accountability, and reporting deviations.
- CRO: Monitors adherence to cold-chain requirements across sites.
- Courier: Maintains validated shipping conditions during transport.
- QA: Audits cold-chain management and reviews deviation reports.
Accountability
The Sponsor’s Vaccine Supply Chain Lead is accountable for cold-chain compliance. The Investigator is accountable for site-level cold-chain management.
Procedure
1. Vaccine Receipt
1.1 Verify shipment condition, temperature monitors, and integrity upon arrival.
1.2 Document details in Vaccine Receipt Log (Annexure-1).
1.3 Report discrepancies immediately to sponsor and QA.
2. Storage
2.1 Store vaccines in validated refrigerators/freezers with continuous monitoring.
2.2 Maintain temperature ranges (e.g., +2°C to +8°C or per product label).
2.3 Document in Vaccine Storage Log (Annexure-2).
3. Distribution and Transport
3.1 Use validated shippers and cold-chain packaging.
3.2 Document distribution in Vaccine Distribution Log (Annexure-3).
4. Temperature Monitoring
4.1 Use calibrated data loggers with alarms.
4.2 Review temperature records daily.
4.3 Record in Temperature Monitoring Log (Annexure-4).
5. Excursion Management
5.1 Document all excursions in Excursion Log (Annexure-5).
5.2 Notify sponsor QA and regulatory authorities if excursions exceed thresholds.
6. Accountability
6.1 Reconcile doses received, used, destroyed, or returned.
6.2 Record in Vaccine Accountability Log (Annexure-6).
7. Multi-Site Logistics
7.1 Coordinate shipments across sites with validated logistics partners.
7.2 Document in Multi-Site Logistics Log (Annexure-7).
8. Archiving
8.1 Archive all cold-chain records in TMF and ISF.
8.2 Retain records per regulatory requirements.
Abbreviations
- SOP: Standard Operating Procedure
- QA: Quality Assurance
- CRO: Contract Research Organization
- TMF: Trial Master File
- ISF: Investigator Site File
- GCP: Good Clinical Practice
- FDA: Food and Drug Administration
- EMA: European Medicines Agency
- CDSCO: Central Drugs Standard Control Organization
- WHO: World Health Organization
Documents
- Vaccine Receipt Log (Annexure-1)
- Vaccine Storage Log (Annexure-2)
- Vaccine Distribution Log (Annexure-3)
- Temperature Monitoring Log (Annexure-4)
- Excursion Log (Annexure-5)
- Vaccine Accountability Log (Annexure-6)
- Multi-Site Logistics Log (Annexure-7)
References
- FDA – Vaccine Trial Guidelines
- EMA – Vaccine Storage & Transport Guidance
- CDSCO – Vaccine Cold-Chain Rules
- ICH GCP – Cold Chain and Vaccine Trials
- WHO – Cold Chain and Immunization Guidelines
Version: 1.0
Approval Section
| Prepared By | Ravi Kumar, Vaccine Logistics Officer |
| Checked By | Sunita Reddy, QA Officer |
| Approved By | Dr. Anil Sharma, Head Clinical Operations |
Annexures
Annexure-1: Vaccine Receipt Log
| Date | Shipment ID | Vaccine | Received By | Condition |
|---|---|---|---|---|
| 01/09/2025 | SHIP-101 | COVID-19 Vaccine | Pharmacist | Acceptable |
Annexure-2: Vaccine Storage Log
| Date | Vaccine ID | Storage Temp | Checked By | Status |
|---|---|---|---|---|
| 02/09/2025 | VAC-101 | +4°C | Site Technician | Stable |
Annexure-3: Vaccine Distribution Log
| Date | Shipment ID | Destination | Transporter | Status |
|---|---|---|---|---|
| 03/09/2025 | SHIP-101 | Site-2 | Courier | Delivered |
Annexure-4: Temperature Monitoring Log
| Date | Equipment ID | Min Temp | Max Temp | Reviewed By |
|---|---|---|---|---|
| 04/09/2025 | FRZ-01 | +2°C | +7°C | QA Officer |
Annexure-5: Excursion Log
| Date | Vaccine ID | Excursion | Impact | Corrective Action |
|---|---|---|---|---|
| 05/09/2025 | VAC-101 | +12°C for 4 hrs | Moderate | Investigated – Product Approved for Use |
Annexure-6: Vaccine Accountability Log
| Date | Vaccine ID | Doses Received | Doses Used | Doses Remaining |
|---|---|---|---|---|
| 06/09/2025 | VAC-101 | 1000 | 600 | 400 |
Annexure-7: Multi-Site Logistics Log
| Date | Shipment ID | Sites Covered | Coordinator | Status |
|---|---|---|---|---|
| 07/09/2025 | SHIP-102 | Site-1, Site-2, Site-3 | Logistics Manager | Completed |
Revision History
| Revision Date | Revision No. | Revision Details | Reason for Revision | Approved By |
|---|---|---|---|---|
| 26/08/2025 | 00 | Initial version | New SOP creation | Head Clinical Operations |
For more SOPs visit: Pharma SOP